BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

N/A
indicator

Bse Dollex 30

1D
1M
3M
6M
1Y
5Y
empty graph

Bse Dollex 30 Performance

Day's Range

Low

₹6,706.61

High

₹6,751.25

52 Week Range

Low

₹6,192.92

High

₹8,025.43

Previous Close ₹6,733.35
Day's Range ₹6,706.61 - ₹6,751.25
Open ₹6,711.88
52 Week Range ₹6,192.92 - ₹8,025.43
Volume 0

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 24430.35 26373.20 22182.55
Nifty IT 27276.45 40301.40 25699.10
Nifty Next 50 72685.6 73141.05 59896.10
NIFTY50 USD Index 8874.1 10443.40 8132.40
Nifty Bank 58291.5 61764.85 49954.85
NIFTY Midcap 100 62471.5 62909.55 52032.85
Nifty 500 23433.95 24144.20 20385.65
Nifty Midcap 50 17863.55 17905.00 14804.55
Nifty 100 25464.45 26975.15 22720.45
Nifty FMCG 50196.35 58485.05 45334.15

Latest News

Jul
6
2026
EQUITY Posted on Jul 6th 2026

Sikozy Realtors informs about newspaper advertisement

Pursuant to Regulation 30 of SEBI (LODR) Regulation, 2015, Sikozy Realtors has informed that it has published the newspaper advertisement for Notice given in the newspaper regarding procedure for reduction of share capital of the company in the Business Standard (English) & NavShakti (Marathi) on 4th July, 2026. The necessary clippings are attached.

The above information is a part of company’s filings submitted to BSE.

Read More
Jul
6
2026
EQUITY Posted on Jul 6th 2026

Tomorrow Technologies Global Innovations informs about certificate

As required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Tomorrow Technologies Global Innovations has informed that it enclosed certificate received from the MUFG INTIME INDIA, Registrar and Share Transfer Agent (RTA) for the QUARTER 30-06-2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
6
2026
EQUITY Posted on Jul 6th 2026

Arvaya Healthcare submits board meeting intimation

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘SEBI Listing Regulations’), Arvaya Healthcare has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, July 11, 2026 to, consider and approve: 1. To consider & approve Acquisition of Sushodha Institute of Gastroenterology and approval of Material Related Party Transactions with Bidari Kotresh Anilkumar. 2. To consider and evaluate a proposal for issuance of equity shares on a preferential basis for consideration other than cash (share swap). 3. To constitute Right Issue Committee of a Company. 4. To consider proposal to issue securities to the existing shareholders of the Company on Rights Basis, as may be permitted under applicable law, subject to such regulatory/statutory approvals as may be required. 5. To consider the approval for the postal ballot process and related actions. Further to its communication dated June 22, 2026 the trading window will be closed from July 1, 2026 which shall remain closed till 48 hours after the declaration of Unaudited Financial Results of the Company for the First Quarter ended June 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Read More
Jul
6
2026
EQUITY Posted on Jul 6th 2026

Genomic Valley Biotech informs about certificate

Genomic Valley Biotech has informed that it enclosed the certificate pursuant to Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended on 30th June 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
6
2026
EQUITY Posted on Jul 6th 2026

Digitide Solutions informs about grant of employee stock options

Digitide Solutions has informed that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) and Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, the Nomination and Remuneration Committee of the Board of Directors of the Company has approved the grant of 33,75,059 options to eligible employees of the Company and its subsidiaries under the ESOS 2026. The relevant disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure -A. The above information will also be made available on the Company’s website: www.digitide.com.

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of DOL30 index?

The previous close of DOL30 index is ₹6733.35 as of 2026-07-06.

The total volume of DOL30 index is 0.00 as of 2026-07-06.

The percentage change in value of DOL30 index is 0.55% as of 2026-07-06.

The absolute increase in DOL30 index value since the previous trading day is ₹36.71 as of 2026-07-06.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore